Results 171 to 180 of about 481,484 (270)

Multiplex single‐cell profiling of putative cancer stem cell markers ALDH1, SOX9, SOX2, CD44, CD133 and CD15 in endometrial cancer

Molecular Oncology, EarlyView.
Cancer stem cells are associated with aggressive disease, but a deep characterization of such markers is lacking in endometrial cancer. This study uses imaging mass cytometry to explore putative cancer stem cell markers in endometrial tumors and corresponding organoid models.
Hilde E. Lien, Marta E. Hjelmeland, Hege F. Berg, Rose M. Gold, Kathrine Woie, Lars A. Akslen, Ingfrid S. Haldorsen, Camilla Krakstad   +7 more
wiley   +1 more source

Programming Education for University Freshmen in All Departments in School of Science and Engineering

, 2017
Takafumi Sasakawa, Kou Fujimoto, Shinji Kitagami   +2 more
openalex   +2 more sources

Materials of the All-Russian scientific and practical Conference «STUDY OF HAZARDOUS NATURAL PROCESSES AND GEOTECHNICAL MONITORING IN ENGINEERING SURVEYS»

, 2022

openalex   +1 more source

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

Molecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park, Jae Won Oh, Hyewon Chung, Jung Won Kwon, Yi Rang Na, Kwang Pyo Kim, Seung Hyeok Seok   +6 more
wiley   +1 more source

891 Published By: Blue Eyes Intelligence Engineering & Sciences Publication (BEIESP) © Copyright: All rights reserved. Retrieval Number: B7821129219/2020©BEIESP DOI: 10.35940/ijitee.B7821.019320 Journal Website: www.ijitee.org Gain Error end DNL for Testing ADCs: Optimization in Time Domain

, 2020
Manish Jain, Prof. R P Kumawat
openalex   +1 more source

Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance

Molecular Oncology, EarlyView.
Cellular heterogeneity is a major cause of drug resistance in cancer. Segeren et al. used single‐cell transcriptomics to investigate gene expression events that correlate with sensitivity to the DNA‐damaging drugs gemcitabine and prexasertib. They show that dampened expression of transcription factor FOXM1 and its target genes protected cells against ...
Hendrika A. Segeren, Kathryn A. Wierenga, Frank M. Riemers, Elsbeth A. van Liere, Bart Westendorp   +4 more
wiley   +1 more source

Interface engineering of sulfide electrolytes for all-solid-state lithium batteries

, 2018
Ruochen Xu, Fudong Han, Xiao Ji, Xiulin Fan, J.P. Tu, Chunsheng Wang   +5 more
openalex   +2 more sources

ON EFFICIENT FRACTIONAL CAPUTO-TYPE SIMULTANEOUS SCHEME FOR FINDING ALL ROOTS OF POLYNOMIAL EQUATIONS WITH BIOMEDICAL ENGINEERING APPLICATIONS

, 2023
Mudassir Shams, Nasreen Kausar, Cuauhtémoc Samaniego, Praveen Agarwal, Shams Forruque Ahmed, Shaher Momani   +5 more
openalex   +1 more source

Targeting PRAME directly or via EZH2 inhibition overcomes retinoid resistance and represents a novel therapy for keratinocyte carcinoma

Molecular Oncology, EarlyView.
The study evaluated the function and therapeutic implications of PRAME in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The findings demonstrate that PRAME impairs keratinocyte differentiation pathways. Furthermore, PRAME impairs anticancer response to retinoid compounds in BCC and SCC cells.
Brandon Ramchatesingh, Amelia Martinez Villarreal, Philippe Lefrançois, Jennifer Gantchev, Sriraam Sivachandran, Samy Abou Setah, Ivan V. Litvinov   +6 more
wiley   +1 more source

NET works after all? Engineering robustness through diversity

, 2018
Thierry D.G.A. Mondeel, Stefania Astrologo, Yanfei Zhang, Hans V. Westerhoff   +3 more
openalex   +1 more source